FR2070083B1 - - Google Patents

Info

Publication number
FR2070083B1
FR2070083B1 FR7034457A FR7034457A FR2070083B1 FR 2070083 B1 FR2070083 B1 FR 2070083B1 FR 7034457 A FR7034457 A FR 7034457A FR 7034457 A FR7034457 A FR 7034457A FR 2070083 B1 FR2070083 B1 FR 2070083B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7034457A
Other languages
French (fr)
Other versions
FR2070083A1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson
Original Assignee
Johnson and Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson and Johnson filed Critical Johnson and Johnson
Publication of FR2070083A1 publication Critical patent/FR2070083A1/fr
Application granted granted Critical
Publication of FR2070083B1 publication Critical patent/FR2070083B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/26—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7034457A 1969-09-23 1970-09-23 Expired FR2070083B1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86029669A 1969-09-23 1969-09-23

Publications (2)

Publication Number Publication Date
FR2070083A1 FR2070083A1 (de) 1971-09-10
FR2070083B1 true FR2070083B1 (de) 1974-05-24

Family

ID=25332903

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7034457A Expired FR2070083B1 (de) 1969-09-23 1970-09-23

Country Status (7)

Country Link
US (1) US3729568A (de)
CA (1) CA945069A (de)
DE (1) DE2046119C2 (de)
FR (1) FR2070083B1 (de)
GB (1) GB1325732A (de)
IT (1) IT1059655B (de)
ZA (1) ZA706459B (de)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3882244A (en) * 1971-12-13 1975-05-06 Univ California Method of treating acne with a c{hd 20 {b acid
US3906108A (en) * 1973-10-12 1975-09-16 Johnson & Johnson Stabilized tretinoin cream emulsion
US3932665A (en) * 1974-04-05 1976-01-13 Scott Eugene J Van Process for the treatment of acne vulgaris utilizing retinal
US4021573A (en) * 1974-04-22 1977-05-03 The Regents Of The University Of California Psoriasis treatment with retinoic acid analogs
US3934028A (en) * 1974-04-22 1976-01-20 The Regents Of The University Of California Acne and psoriasis treatment with retinoic acid analogs
IN142640B (de) * 1975-01-17 1977-08-06 Johnson & Johnson
US4126697A (en) * 1975-11-03 1978-11-21 Johnson & Johnson Retinoic acid derivatives in the treatment of acne
US4190594A (en) * 1975-11-03 1980-02-26 Johnson & Johnson Retinoic acid derivatives
US4108880A (en) * 1975-11-03 1978-08-22 Johnson & Johnson Esters of retinoic acid
US4055659A (en) * 1975-11-03 1977-10-25 Johnson & Johnson Retinoic acid derivatives
US4034114A (en) * 1976-09-15 1977-07-05 Yu Ruey J Treatment of skin keratoses with retinal
SE7612936L (sv) * 1976-11-19 1978-05-20 Pharmacia Ab Hygienisk-kosmetiska kompositioner
US4200647A (en) * 1977-12-21 1980-04-29 Hoffmann-La Roche Inc. Vitamin A compositions to treat rheumatic disease
US4170229A (en) * 1978-01-16 1979-10-09 Dominion Pharmacal, Inc. Method for improved health care of hair and scalp using a vitamin A aqueous emulsion
US4214000A (en) * 1978-10-30 1980-07-22 Johnson & Johnson Zinc salt of all-trans-retinoic acid for the treatment of acne
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4239781A (en) * 1979-05-03 1980-12-16 Roy Edwards Method for treating skin ailments
US5183817A (en) * 1981-02-17 1993-02-02 Bazzano Gail S Combinations of retinoids and minoxidil-type compounds for hair growth
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US4603146A (en) * 1984-05-16 1986-07-29 Kligman Albert M Methods for retarding the effects of aging of the skin
US4698524A (en) * 1986-07-16 1987-10-06 Honeywell Inc. MESFET logic using integral diode level shifting
US4877805A (en) * 1985-07-26 1989-10-31 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
US4843096A (en) * 1985-06-26 1989-06-27 Stiefel Laboratories, Inc. Treatment of acne
US5019569A (en) * 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
US4889847A (en) * 1986-11-03 1989-12-26 Ortho Pharmaceutical Corporation Prevention of glucocorticoid-induced skin atrophy
IL90069A (en) * 1988-04-26 1994-04-12 Us Health The use of 31 cysts of retinoic acid in the preparation of a drug for the treatment of congenital conjunctivitis
NZ229900A (en) * 1988-08-02 1992-03-26 Kligman Albert M Compositions for the treatment of periodontoclasia and gingivitis comprising retinoic acid
US4985235A (en) * 1988-08-02 1991-01-15 Kligman Albert M Treatment of periodontoclasia with retinoic acid
US6028105A (en) * 1989-04-06 2000-02-22 Nigra; Thomas P. Topical drug delivery composition and method
MY105521A (en) * 1989-04-17 1994-10-31 Healthpoint Ltd Moisturizing vehicle for topical application of vitamin a acid.
US5124313A (en) * 1989-06-02 1992-06-23 Schaeffer Hans A Methods of improved skin care and the treatment of dermatological conditions
EP0481007B1 (de) 1989-06-07 1997-01-22 BAZZANO, Gail S VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL
US5380764A (en) * 1989-06-08 1995-01-10 Herzog; Paul Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use
GB9006785D0 (en) * 1990-03-27 1990-05-23 Leung Lit Hung Composition and methods for treatment of acne vulgaris and retardation of ageing
US5273739A (en) * 1990-12-07 1993-12-28 Jim Baral Composition and treatment for darkening hair color
US5051449A (en) 1991-02-27 1991-09-24 Kligman Albert M Treatment of cellulite with retinoids
JPH06507178A (ja) * 1991-09-24 1994-08-11 ファイザー　インク レチノイド類、並びに皮膚疾患及び白血病の治療におけるそれらの使用法
AU667519B2 (en) * 1992-02-07 1996-03-28 Albert M. Kligman Methods of treating inflammatory dermatoses
AU670777B2 (en) * 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
ATE266999T1 (de) * 1992-07-13 2004-06-15 Shiseido Co Ltd Dermatologische zusammensetzung
US6344448B1 (en) 1992-09-11 2002-02-05 Stb Family Limited Partnership Composition for the treatment of hair loss
US6133326A (en) 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US6169110B1 (en) 1995-11-21 2001-01-02 Vivant Pharmaceuticals Rejuvenating the skin using a combination of vitamin A and alphahydroxy acids
WO1998036746A1 (en) * 1997-02-21 1998-08-27 Bristol-Myers Squibb Company Use of substituted (5,6)-dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury
US6008254A (en) * 1997-05-09 1999-12-28 Kligman; Douglas E. Method of treating skin disorders with high-strength tretinoin
US6248763B1 (en) 1998-05-19 2001-06-19 Scivoletto Rosemarie Composition for treating skin conditions
US6429218B1 (en) 1997-05-19 2002-08-06 Joseph Scivoletto Method of controlling niacin concentration in lotion
US7179475B1 (en) * 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US6238683B1 (en) * 1998-12-04 2001-05-29 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
ATE338538T1 (de) * 2000-05-01 2006-09-15 Johnson & Johnson Consumer Wasserfreie topische zubereitungen für die haut
US7060732B2 (en) * 2000-12-12 2006-06-13 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US20060189552A1 (en) * 2000-12-12 2006-08-24 Mohan Vishnupad Dispenser for dispensing three or more actives
WO2003057162A2 (en) * 2002-01-04 2003-07-17 Combinatorx, Incorporated Combination for the treatment of immunoinflammatory disorders and proliferative skin diseases
WO2003092617A2 (en) * 2002-05-03 2003-11-13 Combinatorx, Incorporated Combinations for the treatment of inflammatory skin disorders
US7662855B2 (en) * 2004-05-11 2010-02-16 Imaginative Research Associates, Inc. Retinoid solutions and formulations made therefrom
US20060014834A1 (en) * 2004-05-11 2006-01-19 Mohan Vishnupad Retinoid solutions and formulations made therefrom
CA2589633A1 (en) * 2004-12-03 2006-06-08 Nu-Tein Co., Inc. Method for treating skin disorders with xanthophylls
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
WO2008070116A2 (en) * 2006-12-04 2008-06-12 Concert, Llc Topical compositions for treatment of skin conditions
EP2082736A1 (de) * 2008-01-23 2009-07-29 Jean Hilaire Saurat Pharmazeutische Zusammensetzung zur lokalen Anwendung
US8299122B2 (en) * 2008-04-14 2012-10-30 Skinvisible Pharmaceuticals, Inc. Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition
CN104382798A (zh) * 2014-11-28 2015-03-04 李正梅 一种面膜及其制备方法
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL257621A (de) * 1959-11-23
GB901659A (en) * 1959-11-25 1962-07-25 Carolina Julia Cornelia Vintge Ointment for the treatment of acne vulgaris
CA945068A (en) * 1967-10-25 1974-04-09 Albert M. Kligman Composition and method of treating acne

Also Published As

Publication number Publication date
CA945069A (en) 1974-04-09
ZA706459B (en) 1972-04-26
DE2046119C2 (de) 1984-05-30
US3729568A (en) 1973-04-24
IT1059655B (it) 1982-06-21
GB1325732A (en) 1973-08-08
DE2046119A1 (de) 1971-04-22
FR2070083A1 (de) 1971-09-10

Similar Documents

Publication Publication Date Title
FR2070083B1 (de)
AU2270770A (de)
AU429630B2 (de)
AU2355770A (de)
AU442375B2 (de)
AU427401B2 (de)
AU442357B2 (de)
AU442554B2 (de)
AU410358B2 (de)
AU414607B2 (de)
AU417208B2 (de)
AU442538B2 (de)
AU425297B2 (de)
AU442535B2 (de)
AU428074B2 (de)
AU428129B2 (de)
AU428131B2 (de)
AU442463B2 (de)
AU438128B2 (de)
AU442380B2 (de)
AU442285B2 (de)
AT308690B (de)
AR203167Q (de)
AU5988769A (de)
CS148821B1 (de)